The combination therapy of HIF1α inhibitor LW6 and cisplatin plays an effective role on anti-tumor function in A549 cells.
Sign Up to like & getrecommendations! Published in 2019 at "Neoplasma"
DOI: 10.4149/neo_2018_180921n708
Abstract: Hypoxia-inducible factor 1α (HIF1α) has been demonstrated to be involved in the resistance of various human cancer cells to chemotherapies. However, the correlation between HIF1α and the sensitivity of human non-small cell lung cancer (NSCLC)… read more here.
Keywords: cisplatin; lw6; hif1 inhibitor; a549 cells ... See more keywords